Breyanzi CAR-T for Clatterbridge is supplied by Bristol-Myers Squibb
- The Clatterbridge Cancer Centre NHS Foundation Trust
- North West
- Direct award
- 1 July 2026 to 2 July 2026
The Clatterbridge Cancer Centre NHS Foundation Trust bought Breyanzi CAR POS T-Cells, a CAR-T cell therapy, from Bristol-Myers Squibb Pharmaceuticals.
The treatment was commissioned through NHS England, and Bristol-Myers Squibb supplied it direct to the trust. The trust awarded the £140,250 order directly in June 2026. The contract was due to end in July 2026.
- What
- Medicines supply
- Value
- £140,250
- How it was bought
- Direct award
- Dates and next
- Jul 2026 to Jul 2026